We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

119 hedge funds and large institutions have $731M invested in Arena Pharmaceuticals Inc in 2017 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 53 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

231% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 16

138% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 13

138% more capital invested

Capital invested by funds: $307M → $731M (+$425M)

118% more call options, than puts

Call options by funds: $32.6M | Put options by funds: $14.9M

17% more funds holding

Funds holding: 102 → 119 (+17)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
119
Holders Change
+17
Holders Change %
+16.67%
% of All Funds
2.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
31
Increased
53
Reduced
16
Closed
13
Calls
$32.6M
Puts
$14.9M
Net Calls
+$17.7M
Net Calls Change
+$9.46M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$71.4M
2
State Street
State Street
Massachusetts
+$20.4M
3
BlackRock
BlackRock
New York
+$16M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$15.7M
5
DM
Deerfield Management
New York
+$15M

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$24.8M
2
CCM
Camber Capital Management
Massachusetts
-$7.17M
3
OAM
Oxford Asset Management
United Kingdom
-$2.21M
4
AC
Ascend Capital
California
-$1.93M
5
GCP
GSA Capital Partners
United Kingdom
-$1.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$4.57M +$1.1M +47,888 +36%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$4.34M +$703K +30,660 +22%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$3.92M +$888K +38,700 +34%
PC
29
Polar Capital
United Kingdom
$3.83M +$3.44M +150,000 New
PAM
30
Panagora Asset Management
Massachusetts
$3.12M -$161 -7 -0%
ACM
31
Atika Capital Management
New York
$3.11M +$2.8M +122,000 New
Group One Trading
32
Group One Trading
Illinois
$2.98M +$1.08M +47,305 +68%
PVI
33
Pura Vida Investments
New York
$2.85M +$1.76M +76,700 +219%
EI
34
EAM Investors
California
$2.41M +$2.17M +94,435 New
Mirae Asset Global Investments
35
Mirae Asset Global Investments
South Korea
$2.26M -$332K -14,494 -14%
Deutsche Bank
36
Deutsche Bank
Germany
$2.22M -$644K -28,067 -24%
CAM
37
ClariVest Asset Management
California
$2.16M +$1.94M +84,582 New
SCM
38
Sio Capital Management
New York
$1.84M +$62.7K +2,734 +4%
CS
39
Credit Suisse
Switzerland
$1.83M +$344K +15,012 +26%
Norges Bank
40
Norges Bank
Norway
$1.72M – – –
AllianceBernstein
41
AllianceBernstein
Tennessee
$1.7M +$653K +28,461 +75%
American Century Companies
42
American Century Companies
Missouri
$1.66M +$942K +41,082 +172%
OIM
43
Oracle Investment Management
Connecticut
$1.64M +$1.48M +64,373 New
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.62M +$339K +14,800 +30%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$1.6M +$141K +6,136 +11%
IHM
46
Iguana Healthcare Management
New York
$1.53M +$1.38M +60,000 New
Invesco
47
Invesco
Georgia
$1.5M +$1.35M +58,936 New
Morgan Stanley
48
Morgan Stanley
New York
$1.38M +$46.9K +2,047 +4%
Citigroup
49
Citigroup
New York
$1.3M +$747K +32,587 +178%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$1.27M – – –
1
2
3 4 5

ARNA Hedge Fund Activity: Q3 2017 in Review

119 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2017, worth a combined $731M — up 138% from $307M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ARNA positions and 13 closed out — a net gain of 18 holders — while 53 added to existing stakes and 16 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $71.4M. The largest seller was Great Point Partners, cutting an estimated $24.8M.

  • 119 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2017, up from 102 in Q2 2017.
  • Funds reported $731M of Arena Pharmaceuticals Inc stock for Q3 2017, up 138% quarter-over-quarter.
  • 31 funds opened new Arena Pharmaceuticals Inc positions in Q3 2017 and 13 closed out, a net change of +18 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q3 2017 was Fidelity Investments, an estimated $71.4M added.
  • The largest Arena Pharmaceuticals Inc seller in Q3 2017 was Great Point Partners, an estimated $24.8M sold.

Based on aggregated 13F filings for Q3 2017.